Literature DB >> 25758129

Prevalence and factors associated with late HIV diagnosis.

Se-Ying Dai1, Jin-Ji Liu, Yin-Guang Fan, Gui-Su Shan, Hong-Bo Zhang, Ming-Qiang Li, Dong-Qing Ye.   

Abstract

While highly active antiretroviral therapy has been successful in delaying progression into AIDS, late HIV diagnosis remains a major contributor to the mortality and morbidity of AIDS. An epidemiological study was conducted to evaluate the prevalence and factors of late diagnosis and the characteristics of those individuals with late diagnosis in Liuzhou city. Patients with late diagnosis were defined as either those who were diagnosed with AIDS at the time of HIV diagnosis or as those who developed AIDS no more than 1 year after HIV diagnosis. Of 899 participants, 72.6% had a late diagnosis. Common characteristics of those who experienced late diagnosis included older participants, those who were unexpectedly diagnosed while seeking other medical attention, participants who believed they could not acquire HIV from their regular heterosexual partners, those who never considered getting tested for HIV, and patients with unexplained weight loss, angular cheilitis, or prolonged fever prior to HIV diagnosis. On the other hand, those participants who were diagnosed via testing at compulsory rehabilitation centers and those whose annual household income was greater than 30,000 Yuan were less likely to be diagnosed late. These results suggested that late HIV diagnosis is common in Liuzhou city, and it is essential to promote appropriate strategies to detect HIV infections earlier. Strategies that require HIV/AIDS patients to notify their spouse/sexual-partners about their HIV-positive results within one month and start provider-initiated HIV testing and counseling in medical facilities are beneficial to earlier HIV diagnosis.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  China; HIV; factors; late diagnosis; prevalence

Mesh:

Year:  2015        PMID: 25758129     DOI: 10.1002/jmv.24066

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  6 in total

1.  Trends in late HIV diagnosis among men who have sex with men in Jiangsu province, China: Results from four consecutive community-based surveys, 2011-2014.

Authors:  Haiyang Hu; Hongjing Yan; Xiaoyan Liu; Xiaoqin Xu; Jinshui Xu; Tao Qiu; Ling-En Shi; Gengfeng Fu; Xiping Huan; Willi McFarland; Chongyi Wei
Journal:  PLoS One       Date:  2017-03-09       Impact factor: 3.240

2.  Trends in baseline CD4 cell counts and risk factors for late antiretroviral therapy initiation among HIV-positive patients in Shanghai, a retrospective cross-sectional study.

Authors:  Jianjun Sun; Li Liu; Jiayin Shen; Panpan Chen; Hongzhou Lu
Journal:  BMC Infect Dis       Date:  2017-04-19       Impact factor: 3.090

3.  Age-Period-Cohort Analysis of HIV Mortality in China: Data from the Global Burden of Disease Study 2016.

Authors:  Disi Gao; Zhiyong Zou; Wenjing Zhang; Tianqi Chen; Wenxin Cui; Yinghua Ma
Journal:  Sci Rep       Date:  2020-04-27       Impact factor: 4.379

4.  Prevalence of and factors associated with advanced HIV disease among newly diagnosed people living with HIV in Guangdong Province, China.

Authors:  Hongbo Jiang; Jun Liu; Zhimin Tan; Xiaobing Fu; Yingqian Xie; Kaihao Lin; Yao Yan; Yan Li; Yi Yang
Journal:  J Int AIDS Soc       Date:  2020-11       Impact factor: 5.396

5.  Epidemiological factors associated with recent HIV infection among newly-diagnosed cases in Singapore, 2013-2017.

Authors:  Li Wei Ang; Carmen Low; Chen Seong Wong; Irving Charles Boudville; Matthias Paul Han Sim Toh; Sophia Archuleta; Vernon Jian Ming Lee; Yee Sin Leo; Angela Chow; Raymond Tzer-Pin Lin
Journal:  BMC Public Health       Date:  2021-03-02       Impact factor: 3.295

6.  Late HIV Diagnosis: Proposed Common Definitions and Associations With Short-Term Mortality.

Authors:  Hongbo Jiang; Nianhua Xie; Jianhua Liu; Zhixia Zhang; Li Liu; Zhongzhao Yao; Xia Wang; Shaofa Nie
Journal:  Medicine (Baltimore)       Date:  2015-09       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.